MIM1, a highly specific low-molecular-weight inhibitor of MCL-1, demonstrated promise in preclinical studies by inducing apoptosis in leukaemia [36], glioblastoma [37], and melanoma cell lines [38]. The gene discussed is MCL1; the disease is melanoma.